SE8204064D0 - WEEKLY SLEEVING PROCEDURE FOR THIS REPAIR - Google Patents

WEEKLY SLEEVING PROCEDURE FOR THIS REPAIR

Info

Publication number
SE8204064D0
SE8204064D0 SE8204064A SE8204064A SE8204064D0 SE 8204064 D0 SE8204064 D0 SE 8204064D0 SE 8204064 A SE8204064 A SE 8204064A SE 8204064 A SE8204064 A SE 8204064A SE 8204064 D0 SE8204064 D0 SE 8204064D0
Authority
SE
Sweden
Prior art keywords
fibrinogen
factor xiii
antibiotic
sleeving
weekly
Prior art date
Application number
SE8204064A
Other languages
Swedish (sv)
Other versions
SE459848B (en
SE8204064L (en
Inventor
H Redl
T Seelich
Y Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of SE8204064D0 publication Critical patent/SE8204064D0/en
Publication of SE8204064L publication Critical patent/SE8204064L/en
Publication of SE459848B publication Critical patent/SE459848B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A tissue adhesive based on human or animal proteins contains factor XIII, fibrinogen and an antibiotic. In order to achieve a high straining capacity of the adherences and a retarded antimicrobial efficacy, the ratio of factor XIII to fibrinogen, expressed in units of factor XIII per gram of fibrinogen, amounts to at least 500. The antibiotic is chosen among amino-glucosides, beta- lactams, polypeptides or tetracyclines. In a method of producing the tissue adhesive the concentration ratio of factor XIII to fibrinogen is adjusted in a fibrinogen-containing blood plasma fraction by the addition of factor XIII. The antibiotic is added either before deepfreezing or lyophilization of the resulting preparation, or after thawing or reconstitution of the same.
SE8204064A 1981-07-28 1982-07-01 TEXTILE FILM CONTAINING FACTOR XIII, THE FIBRINOGEN AND ANTIBIOTIC, AND SUCH BEFORE ITS PREPARATION SE459848B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0333781A AT369990B (en) 1981-07-28 1981-07-28 METHOD FOR PRODUCING A TISSUE ADHESIVE

Publications (3)

Publication Number Publication Date
SE8204064D0 true SE8204064D0 (en) 1982-07-01
SE8204064L SE8204064L (en) 1983-01-29
SE459848B SE459848B (en) 1989-08-14

Family

ID=3548998

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204064A SE459848B (en) 1981-07-28 1982-07-01 TEXTILE FILM CONTAINING FACTOR XIII, THE FIBRINOGEN AND ANTIBIOTIC, AND SUCH BEFORE ITS PREPARATION

Country Status (14)

Country Link
JP (1) JPH0696039B2 (en)
AR (1) AR227252A1 (en)
AT (1) AT369990B (en)
BE (1) BE893851A (en)
CA (1) CA1168982A (en)
CH (1) CH659187B (en)
DE (1) DE3225102A1 (en)
DK (1) DK157977C (en)
ES (1) ES514441A0 (en)
FR (1) FR2510408B1 (en)
GB (1) GB2102811B (en)
IT (1) IT1157313B (en)
NL (1) NL192665C (en)
SE (1) SE459848B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06102628B2 (en) * 1984-03-27 1994-12-14 イムノ・アクチエンゲゼルシャフト Tissue adhesive manufacturing method
JPS6185304A (en) * 1984-10-01 1986-04-30 Green Cross Corp:The Auxiliary for dental treatment
DE3622642A1 (en) * 1986-07-05 1988-01-14 Behringwerke Ag ONE-COMPONENT TISSUE ADHESIVE AND METHOD FOR THE PRODUCTION THEREOF
AT397203B (en) * 1988-05-31 1994-02-25 Immuno Ag FABRIC ADHESIVE
US4837379A (en) * 1988-06-02 1989-06-06 Organogenesis Inc. Fibrin-collagen tissue equivalents and methods for preparation thereof
NZ229385A (en) * 1989-06-01 1992-02-25 Life Technologies Inc Treatment of processed fish product (surimi) with alpha-2-macroglobulin to neutralise alkaline proteases in the fish
IT1243180B (en) * 1990-07-31 1994-05-24 Nunzio Rapisarda USE OF PHOSPHOMYCIN AND ITS SALTS AS A TOPICAL CICATRIZING AGENT
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US7229959B1 (en) 1990-11-27 2007-06-12 The American National Red Cross Supplemented fibrin matrix delivery systems
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
AU4566893A (en) * 1992-07-18 1994-02-14 Opperbas Holding B.V. A two component fibrin-glue composition for improving in vitro fertilization
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
EP0696201B2 (en) † 1993-03-12 2012-09-19 The American National Red Cross Supplemented tissue sealants, methods of their production and use
US6019993A (en) * 1993-03-30 2000-02-01 Omrix Biopharmaceuticals S.A. Virus-inactivated 2-component fibrin glue
DE19521324C1 (en) * 1995-06-12 1996-10-31 Immuno Ag Tissue adhesive and use thereof as a hemostatic
DE19617369A1 (en) * 1996-04-30 1997-11-06 Immuno Ag Storage-stable fibrinogen preparations
AT406120B (en) 1997-08-28 2000-02-25 Immuno Ag TISSUE ADHESIVE
AT407484B (en) 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag MEDICINES FOR PROMOTING Wound Healing
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
JP4660048B2 (en) 1999-12-23 2011-03-30 シーエスエル、リミテッド Separation of fibrinogen from plasma protease
US6506365B1 (en) 2000-09-25 2003-01-14 Baxter Aktiengesellschaft Fibrin/fibrinogen binding conjugate
IL144446A0 (en) * 2001-07-19 2002-05-23 Prochon Biotech Ltd Plasma protein matrices and methods for their preparation
CA2498212C (en) 2002-09-10 2012-07-17 American National Red Cross Multi-layered hemostatic dressing comprising thrombin and fibrinogen
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
JP2008510476A (en) 2004-08-27 2008-04-10 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Purification of factor XIII polypeptide from biological material
US20090319045A1 (en) 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
WO2006056575A1 (en) 2004-11-23 2006-06-01 Zymogenetics, Inc. Purification of recombinant human factor xiii
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
WO2007035778A2 (en) 2005-09-19 2007-03-29 Histogenics Corporation Cell-support matrix and a method for preparation thereof
WO2008019129A2 (en) 2006-08-04 2008-02-14 Stb Lifesaving Technologies, Inc. Solid dressing for treating wounded tissue
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US20090075891A1 (en) 2007-08-06 2009-03-19 Macphee Martin Methods and dressings for sealing internal injuries
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US20230210958A1 (en) 2021-12-30 2023-07-06 Baxter International Inc. Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359652B (en) * 1979-02-15 1980-11-25 Immuno Ag METHOD FOR PRODUCING A TISSUE ADHESIVE
AT359653B (en) * 1979-02-15 1980-11-25 Immuno Ag METHOD FOR PRODUCING A TISSUE ADHESIVE
WO1981000516A1 (en) * 1979-08-31 1981-03-05 Merck Patent Gmbh Gel containing fibrine and antibiotic for treating infected bones and preparation process thereof

Also Published As

Publication number Publication date
AT369990B (en) 1983-02-25
NL192665B (en) 1997-08-01
NL192665C (en) 1997-12-02
SE459848B (en) 1989-08-14
GB2102811B (en) 1985-01-30
IT1157313B (en) 1987-02-11
ES8306023A1 (en) 1983-05-01
NL8202982A (en) 1983-02-16
JPS5826821A (en) 1983-02-17
JPH0696039B2 (en) 1994-11-30
DK157977C (en) 1990-08-13
FR2510408A1 (en) 1983-02-04
ES514441A0 (en) 1983-05-01
GB2102811A (en) 1983-02-09
DE3225102A1 (en) 1983-02-17
CA1168982A (en) 1984-06-12
IT8222595A0 (en) 1982-07-27
CH659187B (en) 1987-01-15
DE3225102C2 (en) 1990-05-31
DK157977B (en) 1990-03-12
SE8204064L (en) 1983-01-29
FR2510408B1 (en) 1987-02-27
AR227252A1 (en) 1982-09-30
ATA333781A (en) 1982-07-15
DK300682A (en) 1983-01-29
BE893851A (en) 1982-11-16

Similar Documents

Publication Publication Date Title
SE8204064D0 (en) WEEKLY SLEEVING PROCEDURE FOR THIS REPAIR
NZ222551A (en) A method of healing wounds and a method of regenerating bone; pharmaceutical composition of platelet-derived growth factor and insulin-like growth factor
DE69027865D1 (en) COMPOSITIONS containing omega conotoxin peptide derivatives and their use for the treatment of ischemic-like neuronal damage
ATE187646T1 (en) USE OF ACTIVE INGREDIENTS CONTAINING COPPER TO ACCELERATE WOUND HEALING
AU7922991A (en) Infection-resistant compositions, medical devices and surfaces and method for preparing and using same
DE69230670D1 (en) COMPOSITIONS CONTAINING A BLOOD CLOTH POLYMER MATRIX FOR THE ADMINISTRATION OF OSTEOGENIC PROTEINS
DE3479632D1 (en) Fibronolytically active hybrid protein, process for its preparation and pharmaceutical composition
DE69008423D1 (en) Dynamic fixation of porcine acid valves.
DK0429570T3 (en) Osteoinducing preparations
DE3769379D1 (en) INFLAMMATORY ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITIONS AND METHOD FOR CONTROLLING INFLAMMATION.
NO892270L (en) PROCEDURE FOR THE PREPARATION OF PREPARATIONS FOR USE IN THE TREATMENT OF ALCOHOLISM.
AU4844890A (en) Method and apparatus for the rapid thawing of cryopreserved blood, blood components, and tissue
PT87688A (en) HYBRID PROTEIN C AND METHOD FOR ITS PREPARATION
NO873993L (en) PROCEDURE FOR PREPARING FLUORIDE AND CALCIUM PREPARATIONS WITH LONG-RELEASE.
KR900700492A (en) N-heterocyclic propylidene-1,1-bisphosphonic acid, preparation method thereof and pharmaceutical composition
AU4626389A (en) Use of minoxidil for wound healing
IT1205715B (en) PYROGLUTAMIDE DERIVATIVES, NOOTROPIC AGENTS THAT CONTAIN THEM AND PROCEDURE FOR THEIR PREPARATION
KR950700726A (en) Composition for treatment or diagnosis, its manufacturing method and use (COMPOSITION FOR THERAPEUTIC OR DIAGNOSTIC USE, PROCESS FOR ITS PREPARATION AND ITS USE)
DK403384D0 (en) ENTERALLY EFFECTIVE, BIOLOGICALLY ACTIVE PEPTIDE OR PROTEIN AGENTS AND PROCEDURES FOR PRODUCING THEREOF
ES2106031T3 (en) A COMPOSITION INCLUDING A GROWTH FACTOR, ITS METHOD OF OBTAINING AND USE.
FI101597B1 (en) A method of preparing a lyophilized composition for use in photodynamic therapy or diagnosis of a patient
ES2085199B1 (en) A PROCEDURE FOR THE PREPARATION OF A DEPOT FORMULATION.
IT1173473B (en) PROCEDURE FOR THE PREPARATION OF 1,8-DIHYDROXY-10-ACYL-9-ANTRONES, IN PARTICULAR FOR USE IN THE TREATMENT OF PSORIASIS
EP0331327A3 (en) Agent for blocking nonspecific adsorption, process for preparing thereof and method of blocking nonspecific adsorption
IE840977L (en) Pharmaceutical preparations

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8204064-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8204064-3

Format of ref document f/p: F